Bamboo Therapeutics, a biotechnology company focused on developing gene therapies for rare neurological diseases, has acquired the viral gene therapy manufacturing facility—Vector Core—from the University of North Carolina (UNC) at Chapel Hill, NC. Financial Details were not disclosed. The Vector Core was founded in 1993 as a full-service viral vector production organization with extensive experience in vector design and process development, as well as manufacturing of research and clinical g...